why choose us

First received: August 03, 2023

Clinical Trial: Atorvastatin for Preventing Disease Metastasis in Patients With Resected High-Risk Stage IIA Melanoma

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Clinical Stage IIA Cutaneous Melanoma AJCC v8

Study Type: INTERVENTIONAL


Official Title: A Decentralized Phase II Randomized Controlled Trial of Atorvastatin in Resected High-Risk Melanoma

Brief Summary: This clinical trial tests whether atorvastatin prevents metastasis of resected high-risk stage IIA melanoma.The vast majority of melanomas are diagnosed at an early, localized stage.However, approximately 10-15% of these localized melanomas will eventually metastasize, despite appropriate local treatment.Once metastasis occurs, median survival is less than two years.Melanomas at high risk of metastasis can be identified by gene expression profiling.The investigators aim to treat these high risk melanomas to…

Read more